Literature DB >> 10391086

Silencing of the CD44 gene by CpG methylation in a human gastric carcinoma cell line.

S Sato1, H Yokozaki, W Yasui, H Nikai, E Tahara.   

Abstract

We analyzed 8 human gastric carcinoma cell lines for the expression of CD44 by northern blot analysis and reverse transcription-polymerase chain reaction (RT-PCR), and identified 1 cell line MKN-28 that did not express CD44. In an attempt to clarify the mechanism responsible for the inactivation of CD44 gene expression in this cell line, we investigated the methylation status around the promoter region of CD44 gene by digestion of the DNA with the methylation-sensitive restriction enzyme HpaII. The promoter region of CD44 in MKN-28 revealed hypermethylation, whereas other CD44-positive cell lines did not. Furthermore, treatment of MKN-28 with the demethylating agent 5-azacytidine restored the expression of the gene. These results suggest that CD44 expression is controlled by a DNA hypermethylation mechanism in MKN-28.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391086      PMCID: PMC5926100          DOI: 10.1111/j.1349-7006.1999.tb00773.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  28 in total

1.  Time dependence of X gene reactivation induced by 5-azacytidine: possible progressive restructuring of chromatin.

Authors:  N Homman; S Heuertz; M C Hors-Cayla
Journal:  Exp Cell Res       Date:  1987-10       Impact factor: 3.905

2.  CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis.

Authors:  R Ristamäki; H Joensuu; K O Söderström; S Jalkanen
Journal:  J Pathol       Date:  1995-07       Impact factor: 7.996

3.  Significance of CD44 gene products for cancer diagnosis and disease evaluation.

Authors:  Y Matsumura; D Tarin
Journal:  Lancet       Date:  1992-10-31       Impact factor: 79.321

4.  Expression of CD44R1 adhesion molecule in colon carcinomas and metastases.

Authors:  K K Tanabe; L M Ellis; H Saya
Journal:  Lancet       Date:  1993-03-20       Impact factor: 79.321

5.  Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.

Authors:  N Fujita; N Yaegashi; Y Ide; S Sato; M Nakamura; I Ishiwata; A Yajima
Journal:  Cancer Res       Date:  1994-07-15       Impact factor: 12.701

6.  CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.

Authors:  R Stauder; W Eisterer; J Thaler; U Günthert
Journal:  Blood       Date:  1995-05-15       Impact factor: 22.113

7.  Comparison of seven cell lines derived from human gastric carcinomas.

Authors:  T Motoyama; H Hojo; H Watanabe
Journal:  Acta Pathol Jpn       Date:  1986-01

8.  Prognostic value of CD44 splice variants in human stage III cervical cancer.

Authors:  C Kainz; P Kohlberger; C Tempfer; G Sliutz; G Gitsch; A Reinthaller; G Breitenecker
Journal:  Eur J Cancer       Date:  1995-09       Impact factor: 9.162

9.  Expression of epidermal growth factor, transforming growth factor-alpha and their receptor genes in human gastric carcinomas; implication for autocrine growth.

Authors:  K Yoshida; E Kyo; T Tsujino; T Sano; M Niimoto; E Tahara
Journal:  Jpn J Cancer Res       Date:  1990-01

10.  A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps.

Authors:  K H Heider; M Hofmann; E Hors; F van den Berg; H Ponta; P Herrlich; S T Pals
Journal:  J Cell Biol       Date:  1993-01       Impact factor: 10.539

View more
  5 in total

1.  Effect of P-selectin monoclonal antibody on metastasis of gastric cancer and immune function.

Authors:  Jin-Lian Chen; Wei-Xiong Chen; Jin-Shui Zhu; Ni-Wei Chen; Tong Zhou; Ming Yao; Dong-Qing Zhang; Yun-Lin Wu
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

2.  Parathyroid hormone-related protein and ezrin are up-regulated in human lung cancer bone metastases.

Authors:  Xiyun Deng; Sarah H Tannehill-Gregg; Murali V P Nadella; Guangchun He; Andrea Levine; Ya Cao; Thomas J Rosol
Journal:  Clin Exp Metastasis       Date:  2007-03-17       Impact factor: 4.510

3.  CD44v8-10 as a potential theranostic biomarker for targeting disseminated cancer cells in advanced gastric cancer.

Authors:  Eun-Seok Choi; Hyunjin Kim; Hyung-Pyo Kim; Yongdoo Choi; Sung-Ho Goh
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

4.  Engineering Modular Half-Antibody Conjugated Nanoparticles for Targeting CD44v6-Expressing Cancer Cells.

Authors:  Bianca N Lourenço; Rúben F Pereira; Cristina C Barrias; Claudia Fischbach; Carla Oliveira; Pedro L Granja
Journal:  Nanomaterials (Basel)       Date:  2021-01-23       Impact factor: 5.076

5.  The correlation of epithelial-mesenchymal transition-related gene expression and the clinicopathologic features of colorectal cancer patients in Taiwan.

Authors:  Yuan-Chang Dai; Chuan-Yin Fang; Hsin-Yi Yang; Yi-Jun Jian; Shou-Chieh Wang; Yi-Wen Liu
Journal:  PLoS One       Date:  2021-07-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.